68474-13-5

Usage

Uses

Used in Pharmaceutical Industry:
(R)-(1-Methylpiperidin-2-yl)Methanol is used as an intermediate for the synthesis of various drugs and pharmaceuticals, contributing to the development of new and improved medications.
Used as a Chiral Building Block:
In the pharmaceutical industry, (R)-(1-Methylpiperidin-2-yl)Methanol is used as a chiral building block for the production of optically pure drugs, ensuring the desired stereochemistry and enhancing the efficacy and safety of the final product.
Used in Organic Synthesis:
(R)-(1-Methylpiperidin-2-yl)Methanol serves as a reagent in organic synthesis, facilitating the creation of complex molecules with high stereochemical purity, which is essential for the development of innovative pharmaceuticals and bioactive compounds.
Used as a Key Precursor:
In the synthesis of a variety of bioactive compounds and pharmaceuticals, (R)-(1-Methylpiperidin-2-yl)Methanol acts as a key precursor, enabling the production of molecules with specific biological activities and therapeutic properties.

Upstream product

• 88013-95-0 ethyl (S)-(-)-1-methyl-2-pipecolinate 
• 150130-31-7 (S)-N-methyl-2-(tributylstannyl)piperidine 
• 1723-00-8 (R)-(+)-pipecolic acid 
• 41447-17-0 (R)-1-methylpiperidine-2-carboxylic acid 
• 25271-35-6 (R)-1-methyl-piperidine-2-carboxylic acid ; hydrochloride 

Downstream Products

• 444912-55-4 AM₂₂₃₃ 

Relevant academic research and scientific papers

AMINOESTER DERIVATIVES

The invention relates to novel compounds which are both phosphodiesterase 4 (PDE4) enzymeinhibitorsand muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.

Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor

A series of novel aminoalkylindoles was synthesized in an effort to develop compounds that are potent agonists at the CB1 cannabinoid receptor and that are also easily labeled with radioisotopes of iodine for biochemical and imaging studies. 2-Iodophenyl-

Antiinflammation agents

Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism and cell proliferation. The subject compounds contain fused carbocyclic or heterocyclic rings.

Pleuromutilin derivatives as antimicrobials

The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy.

3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release

Novel heterocyclic ether compounds of the formula: STR1 wherein n, *, R1, R2, R3 and y are specifically defined, or pharmaceutically acceptable salts or prodrugs thereof, which are useful in selectively controlling neurotransmitter release; therapeutically-effective pharmaceutical compositions of these compounds; and use of said compositions to selectively control neurotransmitter release in mammals.

Search for Configurationally Stable, Aracemic α-Amino Organolithiums

The search for configurationally stable α-amino carbanions has led to an interesting observation of differing reactivity of diastereomeric organolithiums and to the characterization of aracemic 2-lithio-N-methylpiperidine and 2-lithio-N-methylpyrrolidine as configurationally stable α-aminoorganolithiums.Details for the preparation of these and related α-lithioheterocycles, evaluation of their and configurational stability, and a preliminary evaluation of the stereoselevtivity of their reactions with electrophiles is presented. - Keywords: α-Amino organolithiums; α-amino carbaions; 2-lithiopiperidine; 2-lithiopyrrrolidine; configurationally stable carbanions.